Table 2. Characteristics of patients with pancreatic cancer.
| Characteristics | Number | PCSK9 | χ2 | P | |
|---|---|---|---|---|---|
| Low | High | ||||
| Age, year | |||||
| <65 | 73(61.9%) | 36(49.3%) | 37(50.7%) | 1.869 | P = 0.172 |
| ≥65 | 45(38.1%) | 28(62.2%) | 17(37.8%) | ||
| Sex, n(%) | |||||
| Male | 85(72.0%) | 47(55.3%) | 38(44.7%) | 0.137 | P = 0.712 |
| Female | 33(28.0%) | 17(51.5%) | 16(48.5%) | ||
| Smoke, n(%) | |||||
| Yes | 48(40.7%) | 23(47.9%) | 25(52.1%) | 1.302 | P = 0.254 |
| No | 70(59.3%) | 41(58.6%) | 29(41.4%) | ||
| Drink, n(%) | |||||
| Yes | 32(27.1%) | 11(34.4%) | 21(65.6%) | 6.979 | P < 0.01 |
| No | 86(72.9%) | 53(61.6%) | 33(38.4%) | ||
| Diabetes, n(%) | |||||
| Yes | 18(15.3%) | 11(61.1%) | 7(38.9%) | 0.404 | P = 0.525 |
| No | 100(84.7%) | 53(53.0%) | 47(47.0%) | ||
| Hypertension, n(%) | |||||
| Yes | 30(25.4%) | 19(63.3%) | 11(36.7%) | 1.341 | P = 0.247 |
| No | 88(74.6%) | 45(51.1%) | 43(48.9%) | ||
| T stage, n(%) | |||||
| T1-2 | 50(42.4%) | 30(60.0%) | 20(40.0%) | 1.161 | P = 0.281 |
| T3-4 | 68(57.6%) | 34(60.0%) | 34(60.0%) | ||
| Lymph node invasion | |||||
| Positive | 42(35.6%) | 16(38.1%) | 26(61.9%) | 6.846 | P < 0.01 |
| Negative | 76(64.4%) | 48(63.2%) | 28(36.8%) | ||
| Metastasis | |||||
| Positive | 30(25.4%) | 13(43.4%) | 17(56.7%) | 1.927 | P = 0.165 |
| Negative | 88(74.6%) | 51(58.0%) | 37(42.0%) | ||
| TNM stage(AJCC) | |||||
| I-II | 55(46.6%) | 36(65.5%) | 19(34.5%) | 5.222 | P < 0.05 |
| III-IV | 63(53.4%) | 28(44.4%) | 35(55.6%) | ||
| Tumor differentiation | |||||
| Well-Moderate | 48(40.7%) | 31(64.6%) | 17(35.4%) | 0.604 | P = 0.437 |
| Poor | 39(33.0%) | 22(56.4%) | 17(43.6%) | ||
| Missing | 31(26.3%) | ||||